Drug Topics
MAY 30, 2023
Part of the risk of developing kidney involvement begins when type 1 diabetes mellitus (T1DM) sets in and establishes itself in the patient, with up to 65% of children experiencing acute kidney injury during T1DM onset, which can further predispose to the development of future chronic kidney disease.
PhRMA
MAY 30, 2023
As we recognize Mental Health Awareness Month, I had the opportunity to connect with PhRMA board member Barry Greene, CEO of Sage Therapeutics, about the company’s efforts to address mental health.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MAY 30, 2023
Quality of life (QOL) for people living with autoimmune diseases benefits from an integrated approach that considers individual immune system sensitivities and patients’ life circumstances, a new study shows.
PharmaVoice
MAY 30, 2023
Walgreens leaders are not deterred and hope to fill the holes left behind by the pharmacy giant.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MAY 30, 2023
The World Health Organization (WHO) shared their enthusiasm for the “appropriate” use of new technologies, and urged safety and caution as automation becomes normalized in the health care sphere.
Fierce Healthcare
MAY 30, 2023
Denials of health insurance claims are rising—and getting weirder pminemyer Tue, 05/30/2023 - 10:51
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MAY 30, 2023
Individuals administered oral semaglutide 50 mg achieved a statistically significant weight loss of approximately 17.4% after 68 weeks, according to Novo Nordisk.
Drug Topics
MAY 30, 2023
Collaboration between providers and payers can help remove the stigmas associated with mental health disorders.
Fierce Healthcare
MAY 30, 2023
Long COVID described as a 'syndrome of syndromes' in NIH funded research fdiamond Tue, 05/30/2023 - 12:16
Drug Topics
MAY 30, 2023
The panelists provide key takeaways from this discussion surrounding treatment-resistant depression.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
MAY 30, 2023
UnitedHealthcare, docs still at odds over prior authorization policy for colonoscopies fdiamond Tue, 05/30/2023 - 17:17
Pharmacy Times
MAY 30, 2023
Untreated hearing loss can affect communication, loneliness, and lead to severe illness, such as dementia.
Pharmaceutical Technology
MAY 30, 2023
SK Bioscience has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for its Covid-19 vaccine, SKYCovion. SKYCovion is intended for the prevention of Covid-19 resulting from SARS-CoV-2 infection in individuals aged 18 years and above. The authorisation allows the distribution of the vaccine in Scotland, Wales and England.
Pharmacy Times
MAY 30, 2023
A professional with a newly-minted pharmacy doctorate degree today has many options for a rewarding career.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
MAY 30, 2023
Medicaid work requirements dropped in debt ceiling deal pminemyer Tue, 05/30/2023 - 12:20
Pharmacy Times
MAY 30, 2023
In the initial cohort, 63% of patients with advanced melanoma achieved an objective response rate, including 6 who had a complete response and 19 who had a partial response to the combination of fianlimab and cemiplimab.
Fierce Pharma
MAY 30, 2023
Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit zbecker Tue, 05/30/2023 - 10:24
Pharmacy Times
MAY 30, 2023
Sue Ojageer discusses the new coloring book she created to explore different pharmaceutical career paths.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
MAY 30, 2023
After price cuts, Eli Lilly inks $13.
Fierce Healthcare
MAY 30, 2023
Ascension down nearly $1.
pharmaphorum
MAY 30, 2023
The benefits of adopting a truly digital mindset for pharmaceuticals Mike.
Fierce Healthcare
MAY 30, 2023
Advocate Health reports 0.
pharmaphorum
MAY 30, 2023
Parkinson’s wearable matches experts in clinical trial Phil.
STAT
MAY 30, 2023
A federal appeals court ruled Tuesday Purdue Pharma can shield its owners — members of the wealthy Sackler family — from thousands of lawsuits over the role the company played in the opioid crisis in exchange for a contribution of up to $6 billion to a proposed bankruptcy settlement. The Sackler family members insisted a bankruptcy deal would not be possible unless they were released from all future liability related to the harm caused by Purdue’s OxyContin painkiller.
pharmaphorum
MAY 30, 2023
UK funds extended reality projects for mental health Phil.
STAT
MAY 30, 2023
The phenomenon of being “Cali sober” is taking the recovery world by storm. It is defined as dedicating oneself to a life free of drugs and alcohol — except for cannabis and other psychedelics. (Though many consumers don’t think of cannabis as a psychedelic, policy experts often consider it one because of its effects.) Hardcore proponents of abstinence-based recovery, such as Alcoholics Anonymous, dismiss the Cali sober approach as dangerous and “not really rec
pharmaphorum
MAY 30, 2023
Elizabeth Holmes due to start prison sentence today Phil.
STAT
MAY 30, 2023
S TAT is putting together a list of books and podcasts that deal with health, medicine, and the life sciences that would be great to check out this summer. We invite our readers to fill out the form below, and you may see your pick in our upcoming annual roundup. To get a little inspiration, check out our past lists from 2022 , 2021 , and 2019.
The Checkup by Singlecare
MAY 30, 2023
Most people have heard of the prostate, but only a few can tell you what it actually does. This small part of the male reproductive system plays a not-so-small role in male fertility by helping to produce semen, and the prostate’s proximity to the bladder means it can also impact urination. “For a gland the size of a walnut that’s tucked away out of sight and out of mind, a man’s prostate can have its fair share of problems,” says David Samadi , MD, a New York City-based prostate cancer surgeon
STAT
MAY 30, 2023
Stimwave’s pitch was alluring. As a startup tackling chronic pain with nerve-stimulating devices, it promised to release patients from the stranglehold of addictive painkillers. And unlike its competitors, whose devices required patients to have clunky batteries implanted in their bodies, Stimwave’s system came with a sleek, wearable battery attached to thin wires under the skin.
PharmExec
MAY 30, 2023
Inpefa to support multiple cardiovascular issues.
STAT
MAY 30, 2023
Since the pandemic began, thousands of child care locations have closed , exacerbating an already acute shortage. But health care worker Jada Carter was lucky. Her two children went to Hospitots, one of the few places to stay open during the early days of the pandemic, when, by one estimate , two-thirds of child care centers closed.
Drug Store News
MAY 30, 2023
Drug Store News caught up with Leon Nicholas, vice president of retail insights and solutions, to talk about the three top trends happening in the retail world today.
Expert insights. Personalized for you.
469 
Let's personalize your content